Internal Medicine · Manati, PR
NPI
1043310550
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
J23 Calle Elliot Velez, Urb Atenas
Manati, PR, 00674
Phone (787) 854-3851
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
181 services
Medicare patients, 2024
30
Average age 75
Drug cost, 2024
$2.6M
42,184 prescriptions
Company payments, 2025
$86.39
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel Padilla Rosa was code 99213 (office e&m - established), 45 times for 19 patients. In total Samuel Padilla Rosa billed 181 services in 13 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 45 | 19 | $66.79 | $3,006 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 14 | 14 | $127.90 | $1,791 |
By year: 2022 $14K for 196 services; 2023 $13K for 189 services; 2024 $13K for 181 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samuel Padilla Rosa prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,844 prescriptions and refills. In total Samuel Padilla Rosa wrote 42,184 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,844 | 7,645 | 827 | $32K |
| Gabapentin Generic | 2,242 | 4,470 | 586 | $24K |
| Pantoprazole Sodium Generic | 1,545 | 1,847 | 252 | $12K |
| Famotidine Generic | 1,519 | 1,783 | 278 | $8,921 |
| Omeprazole Generic | 1,405 | 1,623 | 218 | $8,334 |
| Levothyroxine Sodium Generic | 1,356 | 3,590 | 320 | $19K |
| Synthroid Levothyroxine Sodium | 1,183 | 2,841 | 259 | $114K |
| Lisinopril Generic | 986 | 2,648 | 280 | $6,164 |
| Losartan Potassium Generic | 915 | 2,487 | 264 | $13K |
| Montelukast Sodium Generic | 895 | 1,661 | 251 | $10K |
| Rosuvastatin Calcium Generic | 826 | 2,084 | 240 | $11K |
| Metoprolol Succinate Generic | 729 | 1,959 | 208 | $13K |
| Clonazepam Generic | 716 | 716 | 93 | $4,215 |
| Alendronate Sodium Generic | 678 | 1,566 | 195 | $6,792 |
| Amlodipine Besylate Generic | 654 | 1,691 | 192 | $3,699 |
Brand drugs: 5,699 claims; generic drugs: 35,777 claims; opioid claims: 304.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samuel Padilla Rosa $86.39 ($86.39 in general payments such as food, travel and fees) from 2 companies. The largest payer was Merck Sharp & Dohme LLC with $62.98.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.